Analysis of the Activation Profile of Dendritic Cells Derived from the Bone Marrow of Interleukin-12/interleukin-23-deficient Mice
Overview
Authors
Affiliations
We have previously shown that macrophages from interleukin (IL)-12p40 gene knockout (IL-12/IL-23-/-) mice have a bias towards the M2 activation profile, spontaneously secreting large quantities of transforming growth factor-beta1 (TGF-beta1) and producing low levels of nitric oxide (NO) in response to lipopolysaccharide (LPS) and interferon-gamma (IFN-gamma). To verify whether the activation profile of dendritic cells (DCs) is also influenced by the absence of IL-12/IL-23, bone marrow-derived DCs from IL-12/IL-23-/- and C57BL/6 mice were evaluated. At first we noticed that approximately 50% of the C57BL/6 DCs were dead after LPS-induced maturation, whereas the mortality of IL-12/IL-23-/- DCs was < 10%, a protective effect that diminished when recombinant IL-12 (rIL-12) was added during maturation. Similarly to macrophages, mature IL-12/IL-23-/- DCs (mDCs) produced higher levels of TGF-beta1 and lower levels of NO than C57BL/6 mDCs. NO release was IFN-gamma-dependent, as evidenced by the poor response of IFN-gamma-/- and IL-12/IL-23-/-IFN-gamma-/- mDCs. Nevertheless, IFN-gamma deficiency was not the sole reason for the weak NO response observed in the absence of IL-12/IL-23. The high level of TGF-beta1 secretion by IL-12/IL-23-/- mDCs could explain why exogenous IFN-gamma partially restored the NO production of IFN-gamma-/- mDCs, while IL-12/IL-23-/- IFN-gamma-/- mDCs remained unresponsive. We also showed that CD4+ T-cell proliferation was inhibited by C57BL/6 mDCs, but not by IL-12/IL-23-/- mDCs. IFN-gamma and NO appear to mediate this antiproliferative effect because this effect was not observed in the presence of mDCs from IFN-gamma-/- or IL-12/IL-23-/- IFN-gamma-/- mice and it was attenuated by aminoguanidine. We conclude that the presence of IL-12/IL-23 during LPS-induced maturation influences the activation profile of DCs by a mechanism that is, only in part, IFN-gamma dependent.
Friedel J, Pierre S, Kolbinger A, Schaufele T, Aliraj B, Weigert A Front Immunol. 2024; 15:1353922.
PMID: 38745645 PMC: 11091258. DOI: 10.3389/fimmu.2024.1353922.
Mechanisms and Effects of Isorhamnetin on Imiquimod-Induced Psoriasiform Dermatitis in Mice.
Wu C, Lin C, Chen Y, Yang D Life (Basel). 2022; 12(12).
PMID: 36556472 PMC: 9786590. DOI: 10.3390/life12122107.
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview.
Schinocca C, Rizzo C, Fasano S, Grasso G, Barbera L, Ciccia F Front Immunol. 2021; 12:637829.
PMID: 33692806 PMC: 7937623. DOI: 10.3389/fimmu.2021.637829.
Guan Q, Weiss C, Wang S, Qing G, Yang X, Warrington R Inflamm Bowel Dis. 2018; 24(9):1941-1952.
PMID: 29788053 PMC: 6205364. DOI: 10.1093/ibd/izy142.
Tan G, Wang Z, Che L, Yin S Front Med China. 2014; 1(1):41-5.
PMID: 24557615 DOI: 10.1007/s11684-007-0008-4.